Spanish asthma patients under the microscope: Tezepelumab's Real-World impact

NCT ID NCT07013760

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 21, 2026 · Updated 36 times

Summary

This study looked back at medical records of 420 people with severe asthma in Spain who were given the drug tezepelumab after it was approved. The goal was to describe their characteristics, like age and smoking history, and track how well their asthma was controlled over time. It did not test a new treatment but gathered real-world information on how the drug performs outside of clinical trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Andalucia, Spain
Research Site

C. Valenciana, Spain
Research Site

C. Y Leon, Spain
Research Site

Cantabria, Spain
Research Site

Castilla La Mancha, Spain
Research Site

Cataluna, Spain
Research Site

Extremadura, Spain
Research Site

Galicia, Spain
Research Site

Islas Canarias, Spain
Research Site

Madrid, Spain
Research Site

Navarra, Spain
Research Site

Pais Vasco, Spain

Conditions

Explore the condition pages connected to this study.

ASTHMA